Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in local manufacture of active pharmaceutical ingredients. An increasing number of firms are limiting their Australian involvement to the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to purely distribution.
Like the global pharmaceutical industry, the domestic industry is currently contending with the fallout of the patent cliff. Since 2011, some of the world's highest selling drugs have already lost or are due to lose patent protection... purchase to read more
Industry Report - Industry Key Buyers Chapter
Industry concentration measures the extent to which a few players dominate an industry. Over the past two decades there has been a marked increase in the level of concentration in the global pharmaceutical industry, as major players have continued to merge, driven by the escalating costs of research and development, shorter exclusivity times and the need for global marketing power. The number of major players is expected to continue its downward trend in the immediate to medium-term future, especially as they continue to lose market share in the new post-blockbuster era. In contrast, smaller specialty and biotech pharmaceutical players are expected to gain ground, boosted by the emergence of new biotech-based blockbuster drugs... purchase to read more